Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery

NCT01547728 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT01547728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01547728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response of Recombinant Antithrombin in Heparin Resistant Patients Undergoing Cardiac Surgery
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2012
Completion date
February 28, 2014
Enrollment
42 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thrombophilia due to acquired antithrombin iii deficiency